Executive Board

Dr. Oleg SHARAPOV - President / CEO

Dr. Oleg Sharapov, Doctor of Economical Sciences, has directed very diverse technological and scientific projects ranging from gas production, where he worked and was a Director of different companies working with the GAZPROM holding, to development of anticancer drugs in collaboration with Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of Russian Academy of Sciences. Dr. Sharapov is the author of several publications on management under specific conditions of Russian economical development.

Dr. Sharapov also holds a Master of Sciences degree in physics with specialization in optical spectroscopy. He has developed and is involved in development and quality control of functionalized fluorescent labels based on CdSe/ZnS semiconductor nanocrystals.

Dr. Alexander CHUVURIN - Chief Technology Director

Dr. Chuvurin holds professor appointment at the Kharkov University. Doctor of Sciences in Chemistry, Ph.D. and Doctor of Pharmaceutical Sciences, Mr. Chuvurin has over 150 scientific publications and 122 International and ex-USSR patents in the fields of organic, physical and pharmaceutical chemistry and pharmacology.

Dr. Chuvurin has developed the following 6 original synthetic pharmacological medications:

Phensuccinal is non-steroidal anabolic medication which stimulates regeneration of pancreatic β-cells and inhibits auto-aggressive destruction of the insulin-producing machinery and development of diabetic polyendocrynopathies.

Succiban is a hypoglycemic anti-inflammation medication, which inhibits cellular immune reply and enhances regeneration processes.

Diacamph (Camphoxid) is a hypoglycemic medication with a protective β-cytotropic mechanism of activity.

Glucobolyl is a non-steroidal anabolic medication which normalizes glucose's homeostasis, oxygenesis of the tissues and enhances the working capabilities in the extreme conditions.

Radinal is a radio-protecting compound which increases resistance to the ionizing radiation and elimination of incorporating radio-nuclides from the human body.

Adaptamine is an adaptogenic protector for post-radiation syndrome which inhibits autoimmune destruction of the thymus.

Prof. Dr. Chuvurin has synthesized and studied the physico-chemical properties and biological activities of more than 800 organic compounds, particularly those participating in major biochemical cycles. He has also studied kinetics, thermodynamics and mechanisms of dozens of original chemical reactions.

Prof. Chuvurin holds numerous National Ukrainian awards for technical achievements, teaching, and patenting.